{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:12:48Z","timestamp":1784045568143,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["JSDW202233"],"award-info":[{"award-number":["JSDW202233"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16197-7","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:06:22Z","timestamp":1779249982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatial nodal pattern refines disease-free survival stratification beyond pathological N stage in resected esophageal squamous cell carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Yongkang","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"16197_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"16197_CR2","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69:1564\u201371.","journal-title":"Gut"},{"key":"16197_CR3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12328-020-01237-x","volume":"13","author":"DJ Uhlenhopp","year":"2020","unstructured":"Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13:1010\u201321.","journal-title":"Clin J Gastroenterol"},{"key":"16197_CR4","doi-asserted-by":"publisher","first-page":"e074962","DOI":"10.1136\/bmj-2023-074962","volume":"385","author":"N Deboever","year":"2024","unstructured":"Deboever N, Jones CM, Yamashita K, Ajani JA, Hofstetter WL. Advances in diagnosis and management of cancer of the esophagus. BMJ. 2024;385:e074962.","journal-title":"BMJ"},{"key":"16197_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21037\/acs.2017.03.14","volume":"6","author":"TW Rice","year":"2017","unstructured":"Rice TW, Patil DT, Blackstone EH. 8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6:119\u201330.","journal-title":"Ann Cardiothorac Surg"},{"key":"16197_CR6","doi-asserted-by":"publisher","first-page":"doad065","DOI":"10.1093\/dote\/doad065","volume":"37","author":"N Schuring","year":"2024","unstructured":"Schuring N, van Berge Henegouwen MI, Gisbertz SS. History and evidence for state of the art of lymphadenectomy in esophageal cancer surgery. Dis Esophagus. 2024;37:doad065.","journal-title":"Dis Esophagus"},{"key":"16197_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1186\/s12885-019-5761-7","volume":"19","author":"ERC Hagens","year":"2019","unstructured":"Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, et al. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study. BMC Cancer. 2019;19:662.","journal-title":"BMC Cancer"},{"key":"16197_CR8","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3390\/cancers12061592","volume":"12","author":"ERC Hagens","year":"2020","unstructured":"Hagens ERC, van Berge Henegouwen MI, Gisbertz SS. Distribution of lymph node metastases in esophageal carcinoma patients undergoing upfront surgery: a systematic review. Cancers (Basel). 2020;12:1592.","journal-title":"Cancers (Basel)"},{"key":"16197_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.humpath.2021.05.003","volume":"114","author":"AK Lam","year":"2021","unstructured":"Lam AK, Bourke MJ, Chen R, Fiocca R, Fujishima F, Fujii S, et al. Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol. 2021;114:54\u201365.","journal-title":"Hum Pathol"},{"key":"16197_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-016-0551-7","volume":"14","author":"Japan Esophageal Society","year":"2017","unstructured":"Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 11th Edition: part I. Esophagus. 2017;14:1\u201336.","journal-title":"Esophagus"},{"key":"16197_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doad006","volume":"36","author":"S Matsuda","year":"2023","unstructured":"Matsuda S, Takeuchi M, Kawakubo H, Kitagawa Y. Lymph node metastatic patterns and the development of multidisciplinary treatment for esophageal cancer. Dis Esophagus. 2023;36:doad006.","journal-title":"Dis Esophagus"},{"key":"16197_CR12","doi-asserted-by":"publisher","first-page":"15819","DOI":"10.1007\/s00432-023-05359-w","volume":"149","author":"K Lin","year":"2023","unstructured":"Lin K, Li B, Sun Y, et al. Precise pattern of lymphatic spread of esophageal squamous cell carcinoma: results of 1074 patients with N1 disease. J Cancer Res Clin Oncol. 2023;149:15819\u201325.","journal-title":"J Cancer Res Clin Oncol"},{"key":"16197_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doae052","volume":"37","author":"CZ Wang","year":"2024","unstructured":"Wang CZ, Zhang HL, Shang QX, et al. Mapping of lymph node metastasis from esophageal squamous cell carcinoma after neoadjuvant treatment: a prospective analysis from a high-volume institution in China. Dis Esophagus. 2024;37:doae052.","journal-title":"Dis Esophagus"},{"key":"16197_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00432-024-05911-2","volume":"150","author":"G Ye","year":"2024","unstructured":"Ye G, Pan G, Zhu X, et al. Metastatic patterns of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma without neoadjuvant therapy. J Cancer Res Clin Oncol. 2024;150:387.","journal-title":"J Cancer Res Clin Oncol"},{"key":"16197_CR15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/cam4.4399","volume":"11","author":"S Zhang","year":"2022","unstructured":"Zhang S, Liu Q, Li B, et al. Clinical significance and outcomes of bilateral and unilateral recurrent laryngeal nerve lymph node dissection in esophageal squamous cell carcinoma: a large-scale retrospective cohort study. Cancer Med. 2022;11:1617\u201329.","journal-title":"Cancer Med"},{"key":"16197_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/nyas.14427","volume":"1481","author":"Z Wang","year":"2020","unstructured":"Wang Z, Mao Y, Gao S, et al. Lymph node dissection and recurrent laryngeal nerve protection in minimally invasive esophagectomy. Ann N Y Acad Sci. 2020;1481:20\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"16197_CR17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","volume":"384","author":"RJ Kelly","year":"2021","unstructured":"Kelly RJ, Ajani JA, Kuzdzal J, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med. 2021;384:1191\u2013203.","journal-title":"N Engl J Med"},{"key":"16197_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znae038","volume":"111","author":"J Okui","year":"2024","unstructured":"Okui J, Nagashima K, Matsuda S, et al. Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinoma. Br J Surg. 2024;111:znae038.","journal-title":"Br J Surg"},{"key":"16197_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/SLA.0000000000005638","volume":"276","author":"MC Kalff","year":"2022","unstructured":"Kalff MC, Henckens SPG, Voeten DM, et al. Recurrent disease after esophageal cancer surgery: a substudy of the Dutch Nationwide IVORY study. Ann Surg. 2022;276:806\u201313.","journal-title":"Ann Surg"},{"key":"16197_CR20","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1186\/s12885-024-13085-w","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xu W, Wu M, et al. Survival risk stratification based on prognosis nomogram to identify patients with esophageal squamous cell carcinoma who may benefit from postoperative adjuvant therapy. BMC Cancer. 2024;24:1330.","journal-title":"BMC Cancer"},{"key":"16197_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12029-023-00975-8","volume":"55","author":"G Lu","year":"2024","unstructured":"Lu G, Fang W, Lin Y, Huang H. Development of a survival nomogram for esophageal squamous cell carcinoma patients: a population-based analysis. J Gastrointest Cancer. 2024;55:391\u2013401.","journal-title":"J Gastrointest Cancer"},{"key":"16197_CR22","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1245\/s10434-019-07393-w","volume":"26","author":"W Deng","year":"2019","unstructured":"Deng W, Zhang W, Yang J, et al. Nomogram to predict overall survival for thoracic esophageal squamous cell carcinoma patients after radical esophagectomy. Ann Surg Oncol. 2019;26:2890\u20138.","journal-title":"Ann Surg Oncol"},{"key":"16197_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1245\/s10434-023-14308-3","volume":"31","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, He W, Guo P, et al. Development and validation of a recurrence-free survival prediction model for locally advanced esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2024;31:178\u201391.","journal-title":"Ann Surg Oncol"},{"key":"16197_CR24","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","volume":"36","author":"H Yang","year":"2018","unstructured":"Yang H, Liu H, Chen Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol. 2018;36:2796\u2013803.","journal-title":"J Clin Oncol"},{"key":"16197_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","volume":"156","author":"H Yang","year":"2021","unstructured":"Yang H, Liu H, Chen Y, et al. Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg. 2021;156:721\u20139.","journal-title":"JAMA Surg"},{"key":"16197_CR26","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090\u20138.","journal-title":"Lancet Oncol"},{"key":"16197_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa2111380","volume":"386","author":"Y Doki","year":"2022","unstructured":"Doki Y, Ajani JA, Kato K, et al. Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma. N Engl J Med. 2022;386:449\u201362.","journal-title":"N Engl J Med"},{"key":"16197_CR28","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1245\/s10434-023-13634-w","volume":"30","author":"HB Sun","year":"2023","unstructured":"Sun HB, Jiang D, Liu XB, et al. Patterns and influence of lymph nodal metastases after neoadjuvant chemotherapy and surgery for thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2023;30:5205\u201312.","journal-title":"Ann Surg Oncol"},{"key":"16197_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1245\/s10434-023-14135-6","volume":"31","author":"X Huang","year":"2024","unstructured":"Huang X, Jiang D, Jian Z, et al. Identification of optimal parameters for assessing lymph node status of patients with esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2024;31:883\u201391.","journal-title":"Ann Surg Oncol"},{"key":"16197_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00432-024-05967-0","volume":"150","author":"H Zhou","year":"2024","unstructured":"Zhou H, Lin J, Wei W, et al. Frequency and distribution pattern of lymph node metastasis after neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2024;150:476.","journal-title":"J Cancer Res Clin Oncol"},{"key":"16197_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12957-025-03897-w","volume":"23","author":"X Wang","year":"2025","unstructured":"Wang X, Wen D, Feng H, Luo M. Clinical efficacy of different neoadjuvant therapies for resectable esophageal squamous cell carcinoma. World J Surg Oncol. 2025;23:243.","journal-title":"World J Surg Oncol"},{"key":"16197_CR32","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1002\/cam4.4120","volume":"10","author":"H Zhang","year":"2021","unstructured":"Zhang H, Xiao W, Ren P, et al. The prognostic performance of the log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma: a population study of the US SEER database and a Chinese single-institution cohort. Cancer Med. 2021;10:6149\u201364.","journal-title":"Cancer Med"},{"key":"16197_CR33","doi-asserted-by":"publisher","first-page":"1376527","DOI":"10.3389\/fonc.2024.1376527","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li F, Zhu M, et al. Prognostic prediction and comparison of three staging programs for patients with advanced (T2\u2013T4) esophageal squamous carcinoma after radical resection. Front Oncol. 2024;14:1376527.","journal-title":"Front Oncol"},{"key":"16197_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300173","volume":"19","author":"TH Pao","year":"2024","unstructured":"Pao TH, Chen YY, Li SH, et al. Lymph node volume predicts survival in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery. PLoS ONE. 2024;19:e0300173.","journal-title":"PLoS ONE"},{"key":"16197_CR35","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1245\/s10434-021-10665-z","volume":"29","author":"L Zhang","year":"2022","unstructured":"Zhang L, Shao J, Liu Z, et al. Occurrence and prognostic value of perineural invasion in esophageal squamous cell cancer: a retrospective study. Ann Surg Oncol. 2022;29:586\u201397.","journal-title":"Ann Surg Oncol"},{"key":"16197_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/1759-7714.12922","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z, Chen P, Wang F, Lin L, Liu S. Lymphovascular invasion as an independent prognostic indicator in radically resected thoracic esophageal squamous cell carcinoma. Thorac Cancer. 2019;10:150\u20135.","journal-title":"Thorac Cancer"},{"key":"16197_CR37","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.athoracsur.2022.07.052","volume":"115","author":"J Zhou","year":"2023","unstructured":"Zhou J, Zheng J, Chen Y, et al. Lymphovascular and perineural invasion after neoadjuvant therapy in esophageal squamous carcinoma. Ann Thorac Surg. 2023;115:1386\u201394.","journal-title":"Ann Thorac Surg"},{"key":"16197_CR38","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00330-018-5581-1","volume":"29","author":"X Tan","year":"2019","unstructured":"Tan X, Ma Z, Yan L, Ye W, Liu Z, Liang C. Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma. Eur Radiol. 2019;29:392\u2013400.","journal-title":"Eur Radiol"},{"key":"16197_CR39","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1080\/0284186X.2018.1486039","volume":"57","author":"RTHM Larue","year":"2018","unstructured":"Larue RTHM, Klaassen R, Jochems A, Leijenaar RTH, Hulshof MCCM, van Berge Henegouwen MI, et al. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer. Acta Oncol. 2018;57:1475\u201381.","journal-title":"Acta Oncol"},{"key":"16197_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12957-024-03474-7","volume":"22","author":"J Qiu","year":"2024","unstructured":"Qiu J, Zhang Z, Liu J, et al. Nomograms to predict tumor regression grade (TRG) and ypTNM staging in patients with locally advanced esophageal cancer receiving neoadjuvant therapy. World J Surg Oncol. 2024;22:198.","journal-title":"World J Surg Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16197-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16197-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16197-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:03:29Z","timestamp":1784045009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16197-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16197"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16197-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective cohort study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Nanjing Medical University Affiliated Cancer Hospital (IRB No. KY-2025-246-01). Given the retrospective nature of the study and the use of de-identified data, the requirement for informed consent was waived by the Institutional Review Board.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"844"}}